Venous angioplasty failed to provide any clinical benefit in patients with multiple sclerosis (MS) who met Zamboni Doppler flow criteria for chronic cerebrospinal venous insufficiency (CCSVI) in the ...

April 5, 2011 (Chicago, Illinois) — Endovascular treatment of chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis (MS) is safe and can be performed on an outpatient ...

Venous angioplasty can safely improve quality of life in patients with multiple sclerosis (MS), according to 2 abstracts presented March 25, 2012, at the Society of Interventional Radiology (SIR) ...

A randomized, double-blind, sham-controlled trial, Brave Dreams, has shown no clinical or radiological benefit of percutaneous transluminal angioplasty (PTA) to correct chronic cerebrospinal venous ...

Understanding that angioplasty -- a medical treatment used by interventional radiologists to widen the veins in the neck and chest to improve blood flow -- is safe may encourage additional studies for ...

Evaluating patients with multiple sclerosis who have narrowed jugular and azygos veins -- and the value of widening those veins with angioplasty -- warrants careful, well-designed research, according ...

Casting doubt on a controversial theory supporting percutaneous treatment for multiple sclerosis (MS), a new study published online August 14, 2013, ahead of print in PLOS ONE finds no evidence of ...

Researchers report that performing angioplasty (a treatment that involves temporarily inserting and blowing up a tiny balloon inside a clogged artery to help widen it) on veins in the neck and chest ...

The controversial venous angioplasty procedure proposed as a novel treatment for multiple sclerosis by Zamboni and colleagues 1 has generated substantial public debate —for an untested procedure first ...

HealthDay News — Percutaneous transluminal angioplasty (PTA) seems to be safe but ineffective for patients with multiple sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI), ...